{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:12:47Z","timestamp":1792523567201,"version":"4.5.0"},"reference-count":157,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-23-00156"],"award-info":[{"award-number":["24-23-00156"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"award":["24-23-00156"],"award-info":[{"award-number":["24-23-00156"]}],"id":[{"id":"https:\/\/ror.org\/03y2gwe85","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Prostate-specific membrane antigen (PSMA) ligands are currently one of the popular platforms for creating drugs targeted at prostate cancer tumor cells. In this review, we have collected and systematized current approaches to the synthesis of PSMA ligands based on N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-(S)-L-lysine (DCL), the most widely used scaffold in the design of such ligands. The main approaches to each stage of the synthesis of PSMA inhibitors with various structures are considered in detail, and the existing synthetic techniques are compiled and analyzed. We also review examples of using different synthetic pathways for diagnostic and therapeutic drugs based on PSMA ligands. We propose an algorithm for selecting a synthetic route based on the structure of the target ligand.<\/jats:p>","DOI":"10.3390\/ijms27104642","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:53:24Z","timestamp":1779371604000},"page":"4642","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Review of Approaches to the Synthesis of DCL-Based Prostate-Specific Membrane Antigen Ligands"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5302-9160","authenticated-orcid":false,"given":"Nikolai Y.","family":"Zyk","sequence":"first","affiliation":[{"name":"Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1\/3, GSP-1, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina S.","family":"Butakova","sequence":"additional","affiliation":[{"name":"Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1\/3, GSP-1, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7975-0346","authenticated-orcid":false,"given":"Aleksei E.","family":"Machulkin","sequence":"additional","affiliation":[{"name":"Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1\/3, GSP-1, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6796-8241","authenticated-orcid":false,"given":"Elena K.","family":"Beloglazkina","sequence":"additional","affiliation":[{"name":"Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1\/3, GSP-1, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/djh259","article-title":"Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study","volume":"96","author":"Potosky","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/cncr.24283","article-title":"Review of Major Adverse Effects of Androgen-deprivation Therapy in Men with Prostate Cancer","volume":"115","author":"Taylor","year":"2009","journal-title":"Cancer"},{"key":"ref_4","first-page":"533","article-title":"The Impact of Prostate Cancer Treatment on Quality of Life: A Narrative Review with a Focus on Randomized Data","volume":"12","author":"Taylor","year":"2020","journal-title":"Res. Rep. Urol."},{"key":"ref_5","first-page":"2321","article-title":"Enhanced Expression of Prostate-Specific Membrane Antigen Gene in Prostate Cancer as Revealed by in Situ Hybridization","volume":"57","author":"Kawakami","year":"1997","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2007.02635.x","article-title":"Prostate-specific Membrane Antigen (PSMA) Protein Expression in Normal and Neoplastic Tissues and Its Sensitivity and Specificity in Prostate Adenocarcinoma: An Immunohistochemical Study Using Mutiple Tumour Tissue Microarray Technique","volume":"50","author":"Zhang","year":"2007","journal-title":"Histopathology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lauri, C., Chiurchioni, L., Russo, V.M., Zannini, L., and Signore, A. (2022). PSMA Expression in Solid Tumors beyond the Prostate Gland: Ready for Theranostic Applications?. J. Clin. Med., 11.","DOI":"10.3390\/jcm11216590"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41585-024-00900-z","article-title":"Biological Determinants of PSMA Expression, Regulation and Heterogeneity in Prostate Cancer","volume":"22","author":"Bakht","year":"2025","journal-title":"Nat. Rev. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2174\/092986712799034888","article-title":"Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer","volume":"19","author":"Barinka","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3109\/1061186X.2016.1154564","article-title":"Small-Molecule PSMA Ligands. Current State, SAR and Perspectives","volume":"24","author":"Machulkin","year":"2016","journal-title":"J. Drug Target."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"113752","DOI":"10.1016\/j.ejmech.2021.113752","article-title":"PSMA-Targeted Low-Molecular Double Conjugates for Diagnostics and Therapy","volume":"225","author":"Petrov","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/13543776.2021.1878145","article-title":"Inhibitors of Prostate-Specific Membrane Antigen in the Diagnosis and Therapy of Metastatic Prostate Cancer\u2014A Review of Patent Literature","volume":"31","author":"Ha","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"115966","DOI":"10.1016\/j.ejmech.2023.115966","article-title":"A Systematic Review on the Current Status of PSMA-Targeted Imaging and Radioligand Therapy","volume":"263","author":"Capasso","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.7150\/thno.95039","article-title":"Prostate-Specific Membrane Antigen-Targeted Surgery in Prostate Cancer: Accurate Identification, Real-Time Diagnosis, and Precise Resection","volume":"14","author":"Jiao","year":"2024","journal-title":"Theranostics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"c23-00535","DOI":"10.1248\/cpb.c23-00535","article-title":"Targeted Therapy for Prostate Cancer by Prostate-Specific Membrane Antigen-Targeted Small-Molecule Drug Conjugates","volume":"72","author":"Nakajima","year":"2024","journal-title":"Chem. Pharm. Bull."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12551-021-00919-1","article-title":"Metamorphosis of Prostate Specific Membrane Antigen (PSMA) Inhibitors","volume":"14","author":"Nikfarjam","year":"2022","journal-title":"Biophys. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hennrich, U., and Eder, M. (2021). [68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer. Pharmaceuticals, 14.","DOI":"10.3390\/ph14080713"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1078-0432.CCR-22-2875","article-title":"FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer","volume":"29","author":"Fallah","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1158\/1078-0432.CCR-20-4573","article-title":"Diagnostic Performance of 18F-DCFPyL-PET\/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study","volume":"27","author":"Morris","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100132","DOI":"10.1016\/j.adcanc.2025.100132","article-title":"Dysregulated Key Long Non-Coding RNAs TP53TG1, RFPL1S, DLEU1, and HCG4 Associated with Epithelial-Mesenchymal Transition (EMT) in Castration-Resistant Prostate Cancer","volume":"13","author":"Mehrabi","year":"2025","journal-title":"Adv. Cancer Biol. Metastasis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/0929867328666210804092200","article-title":"The Importance of Linkers in the Structure of PSMA Ligands","volume":"29","author":"Uspenskaya","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.euros.2023.05.014","article-title":"State of the Art in Prostate-Specific Membrane Antigen\u2013Targeted Surgery\u2014A Systematic Review","volume":"54","author":"Berrens","year":"2023","journal-title":"Eur. Urol. Open Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1134\/S1070363225605721","article-title":"Organic Chemistry in the Creation of Molecules with Practically Useful Properties","volume":"96","author":"Belyakova","year":"2026","journal-title":"Russ. J. Gen. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"12296","DOI":"10.1021\/acs.jmedchem.4c02626","article-title":"Prodrugs Targeting Prostate-Specific Membrane Antigen against Prostate Cancer","volume":"68","author":"Liolios","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"106889","DOI":"10.1016\/j.bioorg.2023.106889","article-title":"Advances in Non-Radioactive PSMA-Targeted Small Molecule-Drug Conjugates in the Treatment of Prostate Cancer","volume":"141","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41391-021-00394-5","article-title":"Advances in PSMA-Targeted Therapy for Prostate Cancer","volume":"25","author":"Wang","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.emboj.7600969","article-title":"Structure of Glutamate Carboxypeptidase II, a Drug Target in Neuronal Damage and Prostate Cancer","volume":"25","author":"Mesters","year":"2006","journal-title":"EMBO J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1021\/jm070133w","article-title":"Structural Insight into the Pharmacophore Pocket of Human Glutamate Carboxypeptidase II","volume":"50","author":"Majer","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1073\/pnas.0502101102","article-title":"Crystal Structure of Prostate-Specific Membrane Antigen, a Tumor Marker and Peptidase","volume":"102","author":"Davis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/jm000406m","article-title":"Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)","volume":"44","author":"Kozikowski","year":"2001","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1021\/jm0306226","article-title":"Synthesis of Urea-Based Inhibitors as Active Site Probes of Glutamate Carboxypeptidase II: Efficacy as Analgesic Agents","volume":"47","author":"Kozikowski","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"17090","DOI":"10.1021\/ja906844e","article-title":"Chemical Control over Immune Recognition: A Class of Antibody-Recruiting Small Molecules That Target Prostate Cancer","volume":"131","author":"Murelli","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"18034","DOI":"10.1021\/ja509513c","article-title":"Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies","volume":"136","author":"McEnaney","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1039\/C4PY00999A","article-title":"Development of a Polymer Theranostic for Prostate Cancer","volume":"5","author":"Pearce","year":"2014","journal-title":"Polym. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.08.062","article-title":"A Designer Bow-Tie Combination Therapeutic Platform: An Approach to Resistant Cancer Treatment by Simultaneous Delivery of Cytotoxic and Anti-Inflammatory Agents and Radiation","volume":"187","author":"Pathak","year":"2018","journal-title":"Biomaterials"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1039\/C8CC03999B","article-title":"The Efficiency of 18F Labelling of a Prostate Specific Membrane Antigen Ligand via Strain-Promoted Azide\u2013Alkyne Reaction: Reaction Speed versus Hydrophilicity","volume":"54","author":"Wang","year":"2018","journal-title":"Chem. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.bmcl.2019.06.035","article-title":"Synthesis and Biological Evaluation of PSMA-Targeting Paclitaxel Conjugates","volume":"29","author":"Machulkin","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1021\/acs.molpharmaceut.9b00181","article-title":"Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer","volume":"16","author":"Lesniak","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.bmcl.2019.01.040","article-title":"Synthesis and Biological Evaluation of Doxorubicin-Containing Conjugate Targeting PSMA","volume":"29","author":"Ivanenkov","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"126894","DOI":"10.1016\/j.bmcl.2019.126894","article-title":"Design and Synthesis of a Novel BODIPY-Labeled PSMA Inhibitor","volume":"30","author":"Son","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Xiao, D., Duan, X., Gan, Q., Zhang, X., and Zhang, J. (2020). Preparation and Biological Evaluation of [99mTc]Tc-CNGU as a PSMA-Targeted Radiotracer for the Imaging of Prostate Cancer. Molecules, 25.","DOI":"10.3390\/molecules25235548"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1002\/chem.202001795","article-title":"Modular Medical Imaging Agents Based on Azide\u2013Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of 18 F-Labeled PSMA-Tracers for Prostate Cancer Imaging","volume":"26","author":"Szymanski","year":"2020","journal-title":"Chem. A Eur. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1021\/acs.jmedchem.0c01935","article-title":"Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them","volume":"64","author":"Machulkin","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1039\/D2CC04148K","article-title":"Hetero-Diels\u2013Alder Click Reaction of Dithioesters for a Catalyst-Free Indirect 18 F-Radiolabelling of Peptides","volume":"58","author":"Maujean","year":"2022","journal-title":"Chem. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1021\/acs.joc.2c02420","article-title":"Copper-Mediated Radiobromination of (Hetero)Aryl Boronic Pinacol Esters","volume":"88","author":"Mixdorf","year":"2023","journal-title":"J. Org. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm800994j","article-title":"A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer","volume":"52","author":"Maresca","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_47","first-page":"13","article-title":"Synthesis of PSMA-Targeted Small Molecule Glu-Urea-Lys Analogue","volume":"34","author":"Chen","year":"2012","journal-title":"J. Dalian Med. Univ."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/acs.bioconjchem.6b00012","article-title":"New Chelators for Low Temperature Al 18 F-Labeling of Biomolecules","volume":"27","author":"Cleeren","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1039\/C9DT02506E","article-title":"Two Is Better than One: Difunctional High-Affinity PSMA Probes Based on a [CpM(CO)3] (M = Re\/ 99m Tc) Scaffold","volume":"48","author":"Frei","year":"2019","journal-title":"Dalton Trans."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1039\/C9SC03736E","article-title":"Multi-Functionalised Graphene Nanoflakes as Tumour-Targeting Theranostic Drug-Delivery Vehicles","volume":"10","author":"Lamb","year":"2019","journal-title":"Chem. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/C8OB03150A","article-title":"Enzymatic Radiosynthesis of a 18 F-Glu-Ureido-Lys Ligand for the Prostate-Specific Membrane Antigen (PSMA)","volume":"17","author":"Lowe","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11090","DOI":"10.1039\/D0CC03958F","article-title":"Synthesis of a Porphyrin with Histidine-like Chelate: An Efficient Path towards Molecular PDT\/SPECT Theranostics","volume":"56","author":"Yap","year":"2020","journal-title":"Chem. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"S\u00f8borg Pedersen, K., Baun, C., Michaelsen Nielsen, K., Thisgaard, H., Ingemann Jensen, A., and Zhuravlev, F. (2020). Design, Synthesis, Computational, and Preclinical Evaluation of NatTi\/45Ti-Labeled Urea-Based Glutamate PSMA Ligand. Molecules, 25.","DOI":"10.3390\/molecules25051104"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Lahnif, H., Grus, T., Pektor, S., Greifenstein, L., Schreckenberger, M., and R\u00f6sch, F. (2021). Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach. Molecules, 26.","DOI":"10.3390\/molecules26216332"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e202204072","DOI":"10.1002\/anie.202204072","article-title":"Supramolecular Rotaxane-Based Multi-Modal Probes for Cancer Biomarker Imaging**","volume":"61","author":"Holland","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"116687","DOI":"10.1016\/j.bmc.2022.116687","article-title":"Synthesis of a New Bifunctional NODA for Bioconjugation with PSMA Ligand and One-Step Al18F Labeling","volume":"60","author":"Wang","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zhou, H., Liu, Y., Zhang, X., Chen, K., Li, Y., Xu, X., and Xu, B. (2022). A Preliminary Study of PSMA Fluorescent Probe for Targeted Fluorescence Imaging of Prostate Cancer. Molecules, 27.","DOI":"10.3390\/molecules27092736"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"19586","DOI":"10.1021\/acs.jmedchem.4c01910","article-title":"A Prostate-Specific Membrane Antigen-Targeting Small Molecule\u2013Drug Conjugate Strategy to Overcome the Hematological Toxicity of Olaparib","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-014-0063-1","article-title":"Synthesis and Preclinical Evaluation of DOTAGA-Conjugated PSMA Ligands for Functional Imaging and Endoradiotherapy of Prostate Cancer","volume":"4","author":"Weineisen","year":"2014","journal-title":"EJNMMI Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.bmc.2018.04.014","article-title":"Development of a Ga-68 Labeled PET Tracer with Short Linker for Prostate-Specific Membrane Antigen (PSMA) Targeting","volume":"26","author":"Moon","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/acsmedchemlett.3c00087","article-title":"N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors","volume":"14","author":"Gade","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e202404587","DOI":"10.1002\/anie.202404587","article-title":"Enzyme-Activatable Near-Infrared Hemicyanines as Modular Scaffolds for in Vivo Photodynamic Therapy","volume":"63","author":"Cheng","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"117753","DOI":"10.1016\/j.bmc.2024.117753","article-title":"Design, Synthesis and Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Aryl [18F]Fluorosulfate PET Tracers","volume":"106","author":"Wang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/acs.biochem.1c00127","article-title":"Covalent Stabilization of Antibody Recruitment Enhances Immune Recognition of Cancer Targets","volume":"60","author":"Kapcan","year":"2021","journal-title":"Biochemistry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1039\/D1CC05810J","article-title":"Prostate-Specific Membrane Antigen (PSMA) Targeted Singlet Oxygen Delivery via Endoperoxide Tethered Ligands","volume":"58","author":"Wang","year":"2022","journal-title":"Chem. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/acschembio.0c00112","article-title":"Covalent Immune Recruiters: Tools to Gain Chemical Control Over Immune Recognition","volume":"15","author":"Lake","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1021\/acs.bioconjchem.9b00335","article-title":"Prostate-Specific Membrane Antigen-Specific Antitumor Activity of a Self-Immolative Tubulysin Conjugate","volume":"30","author":"Leamon","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1021\/acs.jmedchem.1c00812","article-title":"Synthesis and Preclinical Evaluation of [ 18 F]SiFA-PSMA Inhibitors in a Prostate Cancer Model","volume":"64","author":"Bailey","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2967\/jnumed.119.233064","article-title":"Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye\u2013Protein Interaction","volume":"61","author":"Hensbergen","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/jm990004i","article-title":"Novel Inhibitors of Carboxypeptidase G2 (CPG2): Potential Use in Antibody-Directed Enzyme Prodrug Therapy","volume":"42","author":"Khan","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1021\/jm800111u","article-title":"Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)","volume":"51","author":"Banerjee","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1021\/jm801055h","article-title":"Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer","volume":"51","author":"Chen","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/bc3003919","article-title":"Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen","volume":"23","author":"Chen","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1158\/1078-0432.CCR-11-1357","article-title":"2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer","volume":"17","author":"Chen","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1021\/jo50012a002","article-title":"Cleavage of N-Carbobenzoxy Groups by Dry Hydrogen Bromide and Hydrogen Chloride","volume":"17","author":"Berger","year":"1952","journal-title":"J. Org. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1055\/s-1990-27109","article-title":"Synthesis of 1-Substituted 2-[(2S)-2-Pyrrolidinyl]Pyridine from L-Proline","volume":"1990","author":"Chelucci","year":"1990","journal-title":"Synthesis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1039\/c39740000107","article-title":"Trifluoromethanesulphonic Acid, as a Deprotecting Reagent in Peptide Chemistry","volume":"3","author":"Yajima","year":"1974","journal-title":"J. Chem. Soc. Chem. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.1021\/jo801830x","article-title":"A Scalable Synthesis of an Azabicyclooctanyl Derivative, a Novel DPP-4 Inhibitor","volume":"73","author":"Fei","year":"2008","journal-title":"J. Org. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1002\/chem.201405704","article-title":"99mTc Radiolabeling and Biological Evaluation of Nanoparticles Functionalized with a Versatile Coating Ligand","volume":"21","author":"Felber","year":"2015","journal-title":"Chem. A Eur. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bmcl.2018.01.047","article-title":"Synthesis of Novel Multivalent Fluorescent Inhibitors with High Affinity to Prostate Cancer and Their Biological Evaluation","volume":"28","author":"Kwon","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1021\/acs.bioconjchem.8b00767","article-title":"Synthesis and Evaluation of Multifunctional Fluorescent Inhibitors with Synergistic Interaction of Prostate-Specific Membrane Antigen and Hypoxia for Prostate Cancer","volume":"30","author":"Kwon","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/acs.orglett.0c04054","article-title":"One-Step Synthesis of [18F]Fluoro-4-(Vinylsulfonyl)Benzene: A Thiol Reactive Synthon for Selective Radiofluorination of Peptides","volume":"23","author":"Ma","year":"2021","journal-title":"Org. Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1021\/jm800765e","article-title":"Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization","volume":"51","author":"Barinka","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/mp9000712","article-title":"Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents","volume":"6","author":"Kularatne","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.bmc.2014.05.061","article-title":"Rational Design of Urea-Based Glutamate Carboxypeptidase II (GCPII) Inhibitors as Versatile Tools for Specific Drug Targeting and Delivery","volume":"22","author":"Tykvart","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/anie.201508642","article-title":"IBodies: Modular Synthetic Antibody Mimetics Based on Hydrophilic Polymers Decorated with Functional Moieties","volume":"55","author":"Schimer","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"128840","DOI":"10.1016\/j.bmcl.2022.128840","article-title":"Synthesis and Initial in Vitro Evaluation of PSMA-Targeting Ligands with a Modified Aromatic Moiety at the Lysine \u03b5-Nitrogen Atom","volume":"71","author":"Zyk","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.bmcl.2012.09.014","article-title":"Synthesis and SAR of 99mTc\/Re-Labeled Small Molecule Prostate Specific Membrane Antigen Inhibitors with Novel Polar Chelates","volume":"23","author":"Lu","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1039\/D4CP04137B","article-title":"Balancing Enthalpy and Entropy in Inhibitor Binding to the Prostate-Specific Membrane Antigen (PSMA)","volume":"27","author":"Xiong","year":"2025","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1021\/acs.jmedchem.1c00117","article-title":"Synthesis, Preclinical Evaluation, and First-in-Human PET Study of Quinoline-Containing PSMA Tracers with Decreased Renal Excretion","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Krapf, P., Wicher, T., Zlatopolskiy, B.D., Ermert, J., and Neumaier, B. (2025). Fully Automated Production of (((S)-1-Carboxy-5-(6-([18F]Fluoro)-2-Methoxynicotinamido)Pentyl)Carbamoyl)-l-Glutamic Acid ([18F]JK-PSMA-7). Pharmaceuticals, 18.","DOI":"10.3390\/ph18010119"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2967\/jnumed.118.218495","article-title":"Discovery of 18 F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions","volume":"60","author":"Zlatopolskiy","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/acs.molpharmaceut.2c01101","article-title":"Improve the Biodistribution with Bulky and Lipophilic Modification Strategies on Lys-Urea-Glu-Based PSMA-Targeting Radiotracers","volume":"20","author":"Cai","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13550-024-01071-z","article-title":"Exploring the Impact of PEGylation on Pharmacokinetics: A Size-Dependent Effect of Polyethylene Glycol on Prostate-Specific Membrane Antigen Inhibitors","volume":"14","author":"Liu","year":"2024","journal-title":"EJNMMI Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"116915","DOI":"10.1016\/j.bmc.2022.116915","article-title":"Copper-Mediated Radioiodination and Radiobromination via Aryl Boronic Precursor and Its Application to 125I\/77Br\u2013Labeled Prostate-Specific Membrane Antigen Imaging Probes","volume":"69","author":"Kondo","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1021\/acs.molpharmaceut.9b00464","article-title":"Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy","volume":"16","author":"Wang","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1021\/acs.jmedchem.3c01310","article-title":"7-[18F]Fluoro-8-Azaisatoic Anhydrides: Versatile Prosthetic Groups for the Preparation of PET Tracers","volume":"66","author":"Willmann","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1021\/jo901475d","article-title":"Fluorous Isocyanates: Convenient Synthons for the Preparation of Radioiodinated Compounds in High Effective Specific Activity","volume":"74","author":"Donovan","year":"2009","journal-title":"J. Org. Chem."},{"key":"ref_99","first-page":"100084","article-title":"A Convenient Total Synthesis of PSMA-617: A Prostate Specific Membrane Antigen (PSMA) Ligand for Prostate Cancer Endotherapeutic Applications","volume":"6","author":"Kumar","year":"2022","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nucmedbio.2017.12.007","article-title":"Synthesis and Evaluation of a Novel Urea-Based 68 Ga-Complex for Imaging PSMA Binding in Tumor","volume":"59","author":"Zha","year":"2018","journal-title":"Nucl. Med. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"115319","DOI":"10.1016\/j.bmc.2020.115319","article-title":"Synthesis and Evaluation of Novel Radioiodinated PSMA Targeting Ligands for Potential Radiotherapy of Prostate Cancer","volume":"28","author":"Yao","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/acs.molpharmaceut.9b01179","article-title":"Development of 18 F-Fluoroglycosylated PSMA-Ligands with Improved Renal Clearance Behavior","volume":"17","author":"Potemkin","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1039\/D3CC04787C","article-title":"One-Pot Two-Step Radioiodination Based on Copper-Mediated Iododeboronation and Azide\u2013Alkyne Cycloaddition Reaction","volume":"60","author":"Kondo","year":"2024","journal-title":"Chem. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.1039\/D1TB00777G","article-title":"Synthesis and In Vitro Preliminary Evaluation of Prostate-Specific Membrane Antigen Targeted Upconversion Nanoparticles as a First Step towards Radio\/Fluorescence-Guided Surgery of Prostate Cancer","volume":"9","author":"Cordonnier","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"50569","DOI":"10.1021\/acsami.2c15095","article-title":"Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers","volume":"14","author":"Meher","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"17097","DOI":"10.1021\/jacs.1c07377","article-title":"Magnetic Resonance Imaging of PSMA-Positive Prostate Cancer by a Targeted and Activatable Gd(III) MR Contrast Agent","volume":"143","author":"Li","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1039\/C5NJ03104D","article-title":"Post-Functionalization of Platinum\u2013NHC Complexes by Oxime Ligation for Ligand Targeted Therapy","volume":"40","author":"Dahm","year":"2016","journal-title":"New J. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bbrc.2009.10.017","article-title":"A Low Molecular Weight PSMA-Based Fluorescent Imaging Agent for Cancer","volume":"390","author":"Chen","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1021\/jm100623e","article-title":"68 Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer","volume":"53","author":"Banerjee","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1021\/jm400823w","article-title":"Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA)","volume":"56","author":"Pullambhatla","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/acs.bioconjchem.5b00679","article-title":"Preclinical Comparative Study of 68 Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA","volume":"27","author":"Chen","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/chem.201702335","article-title":"Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy","volume":"24","author":"Wurzer","year":"2018","journal-title":"Chem. A Eur. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1021\/acsmedchemlett.3c00057","article-title":"Modular One-Pot Strategy for the Synthesis of Heterobivalent Tracers","volume":"14","author":"Bailly","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2967\/jnumed.115.158550","article-title":"68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies","volume":"56","author":"Weineisen","year":"2015","journal-title":"J. Nucl. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2967\/jnumed.116.178939","article-title":"Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer","volume":"58","author":"Robu","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.mencom.2020.11.022","article-title":"Influence of the Dipeptide Linker Configuration on the Activity of PSMA Ligands","volume":"30","author":"Uspenskaya","year":"2020","journal-title":"Mendeleev Commun."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Machulkin, A.E., Petrov, S.A., Kraynova, M.D., Garanina, A.S., Egorova, B.V., Timoshenko, R.V., Vaneev, A.N., Erofeev, A.S., Priselkova, A.B., and Kalinin, M.A. (2025). Synthesis of Bispidine-Based Prostate-Specific Membrane Antigen-Targeted Conjugate and Initial Investigations. Organics, 6.","DOI":"10.3390\/org6010007"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"440","DOI":"10.71267\/mencom.7661","article-title":"A Novel Molecular Platform for Co-Delivery of Monomethyl Auristatin E and Ispinesib to Prostate Cancer Cells","volume":"35","author":"Zyk","year":"2025","journal-title":"Mendeleev Commun."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Petrov, S.A., Machulkin, A.E., Uspenskaya, A.A., Zyk, N.Y., Nimenko, E.A., Garanina, A.S., Petrov, R.A., Polshakov, V.I., Grishin, Y.K., and Roznyatovsky, V.A. (2020). Polypeptide-Based Molecular Platform and Its Docetaxel\/Sulfo-Cy5-Containing Conjugate for Targeted Delivery to Prostate Specific Membrane Antigen. Molecules, 25.","DOI":"10.3390\/molecules25245784"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Zyk, N.Y., Garanina, A.S., Plotnikova, E.A., Ber, A.P., Nimenko, E.A., Dashkova, N.S., Uspenskaia, A.A., Shafikov, R.R., Skvortsov, D.A., and Petrov, S.A. (2023). Synthesis of Prostate-Specific Membrane Antigen-Targeted Bimodal Conjugates of Cytotoxic Agents and Antiandrogens and Their Comparative Assessment with Monoconjugates. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411327"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1134\/S1070363225607914","article-title":"Approaches to the Synthesis of Double Conjugates of PSMA Ligands with Monomethyl Auristatin E","volume":"95","author":"Zyk","year":"2025","journal-title":"Russ. J. Gen. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1002\/anie.201102872","article-title":"Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen","volume":"50","author":"Banerjee","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1021\/acs.bioconjchem.6b00222","article-title":"Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics","volume":"27","author":"Kumar","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1039\/D1CC00823D","article-title":"Development of a Novel Radiotheranostic Platform with a DOTA-Based Trifunctional Chelating Agent","volume":"57","author":"Nakashima","year":"2021","journal-title":"Chem. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"54739","DOI":"10.1021\/acsami.1c16383","article-title":"Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen","volume":"13","author":"Meher","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"120553","DOI":"10.1016\/j.ijpharm.2021.120553","article-title":"Sequential Receptor\u2013Mediated Mixed-Charge Nanomedicine to Target Pancreatic Cancer, Inducing Immunogenic Cell Death and Reshaping the Tumor Microenvironment","volume":"601","author":"Shen","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1021\/acs.molpharmaceut.7b00889","article-title":"Inhibitor\u2013GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles","volume":"15","author":"Neburkova","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1021\/ml300003v","article-title":"Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents","volume":"3","author":"Darwish","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/cber.19911240539","article-title":"Anticancer Agents, 15. Squaric Acid Diethyl Ester: A New Coupling Reagent for the Formation of Drug Biopolymer Conjugates. Synthesis of Squaric Acid Ester Amides and Diamides","volume":"124","author":"Tietze","year":"1991","journal-title":"Chem. Ber."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1039\/c3cs60153f","article-title":"Be Squared: Expanding the Horizon of Squaric Acid-Mediated Conjugations","volume":"42","author":"Wurm","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"108867","DOI":"10.1016\/j.apradiso.2019.108867","article-title":"Synthesis and Labeling of a Squaric Acid Containing PSMA-Inhibitor Coupled to AAZTA5 for Versatile Labeling with 44Sc, 64Cu, 68Ga and 177Lu","volume":"156","author":"Greifenstein","year":"2020","journal-title":"Appl. Radiat. Isot."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"9258","DOI":"10.1021\/acs.jmedchem.0c00291","article-title":"Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer","volume":"63","author":"Noor","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/cbic.201900042","article-title":"Cross-Isotopic Bioorthogonal Tools as Molecular Twins for Radiotheranostic Applications","volume":"20","author":"Rosecker","year":"2019","journal-title":"ChemBioChem"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"116545","DOI":"10.1016\/j.ejmech.2024.116545","article-title":"Synthesis and Preclinical Evaluation of 68Ga-Labeled PSMA Tracers with Improved Pharmacological Properties","volume":"274","author":"Hou","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1021\/acs.jmedchem.5b00278","article-title":"Design of Highly Potent Urea-Based, Exosite-Binding Inhibitors Selective for Glutamate Carboxypeptidase II","volume":"58","author":"Tykvart","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1021\/acs.jmedchem.1c00444","article-title":"Visualizing Tumors in Real Time: A Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"13332","DOI":"10.1021\/acs.jmedchem.3c01475","article-title":"Synthesis, Preclinical Evaluation, and First-in-Human PET Study of [68Ga]-Labeled Biphenyl-Containing PSMA Tracers","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bc200279b","article-title":"68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging","volume":"23","author":"Eder","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.jmedchem.5b01210","article-title":"Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors","volume":"59","author":"Klika","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/acs.bioconjchem.5b00687","article-title":"Novel Bispecific PSMA\/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer","volume":"27","author":"Liolios","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Lundmark, F., Olanders, G., Rinne, S.S., Abouzayed, A., Orlova, A., and Rosenstr\u00f6m, U. (2022). Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14051098"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Abouzayed, A., Seitova, K., Lundmark, F., Bodenko, V., Oroujeni, M., Tolmachev, V., Rosenstr\u00f6m, U., and Orlova, A. (2023). 177Lu-Labeled PSMA Targeting Therapeutic with Optimized Linker for Treatment of Disseminated Prostate Cancer; Evaluation of Biodistribution and Dosimetry. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1221103"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1021\/acsomega.1c06342","article-title":"Understanding OxymaPure as a Peptide Coupling Additive: A Guide to New Oxyma Derivatives","volume":"7","author":"Manne","year":"2022","journal-title":"ACS Omega"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1021\/acs.jmedchem.3c00346","article-title":"Development of Novel 111In\/225Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics","volume":"66","author":"Tsuchihashi","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.7150\/thno.52166","article-title":"Photosensitizer-Based Multimodal PSMA-Targeting Ligands for Intraoperative Detection of Prostate Cancer","volume":"11","author":"Derks","year":"2021","journal-title":"Theranostics"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.mencom.2023.06.010","article-title":"Choice of the Optimal Synthetic Approach for the Polypeptide Ligands of Prostatic Specific Membrane Antigen Preparation","volume":"33","author":"Zyk","year":"2023","journal-title":"Mendeleev Commun."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"118433","DOI":"10.1016\/j.ejmech.2025.118433","article-title":"A Series of Conjugates Based on Prostate-Specific Membrane Antigen Ligands with the Chelating Agent DOTA: Synthesis, Radiolabeling, and Biological Activity","volume":"303","author":"Butakova","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Wodtke, R., Pietzsch, J., and L\u00f6ser, R. (2021). Solid-Phase Synthesis of Selectively Mono-Fluorobenz(o)Ylated Polyamines as a Basis for the Development of 18F-Labeled Radiotracers. Molecules, 26.","DOI":"10.3390\/molecules26227012"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/S0040-4039(00)99113-5","article-title":"Trialkylsilanes as Scavengers for the Trifluoroacetic Acid Deblocking of Protecting Groups in Peptide Synthesis","volume":"30","author":"Pearson","year":"1989","journal-title":"Tetrahedron Lett."},{"key":"ref_150","first-page":"100014","article-title":"Total Chemical Synthesis of PSMA-11: API for 68Ga-PSMA-11 Used for Prostate Cancer Diagnosis","volume":"3","author":"Mathur","year":"2021","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1021\/jm5018384","article-title":"DUPA Conjugation of a Cytotoxic Indenoisoquinoline Topoisomerase I Inhibitor for Selective Prostate Cancer Cell Targeting","volume":"58","author":"Roy","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0006-2952(95)02157-4","article-title":"Glutathione and Glutathione S-Transferase in Benign and Malignant Prostate Cell Lines and Prostate Tissues","volume":"51","author":"Canada","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1039\/C6SC01831A","article-title":"Decoupling Stability and Release in Disulfide Bonds with Antibody-Small Molecule Conjugates","volume":"8","author":"Pillow","year":"2017","journal-title":"Chem. Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1039\/C4GC01149J","article-title":"A Survey of Solvent Selection Guides","volume":"16","author":"Prat","year":"2014","journal-title":"Green Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"42457","DOI":"10.1039\/D0RA07204D","article-title":"Greening the Synthesis of Peptide Therapeutics: An Industrial Perspective","volume":"10","author":"Martin","year":"2020","journal-title":"RSC Adv."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1039\/D1GC04387K","article-title":"Sustainability in Peptide Chemistry: Current Synthesis and Purification Technologies and Future Challenges","volume":"24","author":"Ferrazzano","year":"2022","journal-title":"Green Chem."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e70013","DOI":"10.1002\/psc.70013","article-title":"Fundamental Aspects of SPPS and Green Chemical Peptide Synthesis","volume":"31","author":"Kent","year":"2025","journal-title":"J. Pept. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4642\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:55:27Z","timestamp":1779371727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":157,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104642"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104642","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}